Anna Partyka

2.4k total citations
105 papers, 1.9k citations indexed

About

Anna Partyka is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Anna Partyka has authored 105 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 40 papers in Cellular and Molecular Neuroscience and 31 papers in Organic Chemistry. Recurrent topics in Anna Partyka's work include Receptor Mechanisms and Signaling (28 papers), Neurotransmitter Receptor Influence on Behavior (27 papers) and Pharmacological Receptor Mechanisms and Effects (19 papers). Anna Partyka is often cited by papers focused on Receptor Mechanisms and Signaling (28 papers), Neurotransmitter Receptor Influence on Behavior (27 papers) and Pharmacological Receptor Mechanisms and Effects (19 papers). Anna Partyka collaborates with scholars based in Poland, Germany and Armenia. Anna Partyka's co-authors include Anna Wesołowska, Magdalena Jastrzębska‐Więsek, Andrzej J. Bojarski, Maciej Pawłowski, Grzegorz Satała, Marcin Kołaczkowski, Paweł Zajdel, Agata Siwek, Krzysztof Marciniec and Adam Bucki and has published in prestigious journals such as PLoS ONE, Brain Research and International Journal of Molecular Sciences.

In The Last Decade

Anna Partyka

100 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Partyka Poland	26	883	539	529	357	183	105	1.9k
Francesco G. Salituro United States	27	923 1.0×	357 0.7×	462 0.9×	142 0.4×	185 1.0×	45	1.8k
Eleonora Da Pozzo Italy	31	1.1k 1.2×	299 0.6×	580 1.1×	138 0.4×	193 1.1×	99	2.6k
Celia Dominguez United States	27	1.1k 1.3×	697 1.3×	412 0.8×	141 0.4×	72 0.4×	79	2.2k
Patricia Salvati Italy	23	574 0.7×	450 0.8×	405 0.8×	444 1.2×	106 0.6×	61	2.0k
José Á. Morales-García Spain	28	940 1.1×	340 0.6×	431 0.8×	556 1.6×	123 0.7×	56	2.0k
Shil Patel United States	29	1.3k 1.5×	471 0.9×	1.1k 2.1×	150 0.4×	84 0.5×	59	2.4k
Mohammed A. Kashem United States	25	858 1.0×	301 0.6×	456 0.9×	267 0.7×	62 0.3×	58	1.8k
Lawrence P. Wennogle United States	30	1.7k 1.9×	202 0.4×	761 1.4×	404 1.1×	131 0.7×	69	2.6k
Yuemang Yao United States	25	694 0.8×	273 0.5×	372 0.7×	527 1.5×	130 0.7×	37	2.3k
Brian Lockhart France	24	956 1.1×	352 0.7×	450 0.9×	380 1.1×	83 0.5×	51	2.0k

Countries citing papers authored by Anna Partyka

Since Specialization

Citations

This map shows the geographic impact of Anna Partyka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Partyka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Partyka more than expected).

Fields of papers citing papers by Anna Partyka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Partyka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Partyka. The network helps show where Anna Partyka may publish in the future.

Co-authorship network of co-authors of Anna Partyka

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Partyka. A scholar is included among the top collaborators of Anna Partyka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Partyka. Anna Partyka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Śniecikowska, Joanna, Monika Głuch‐Lutwin, Adam Bucki, et al.. (2025). Discovery of NLX-266, an Orally Available and Metabolically Stable ERK1/2-Biased 5-HT_1AR Agonist with Superior Antidepressant and Antiparkinsonian Activity. Journal of Medicinal Chemistry. 68(9). 9706–9722.

Partyka, Anna, et al.. (2023). Zastosowanie aromaterapii klinicznej w infekcjach intymnych kobiet. 7(1). 73–90. 1 indexed citations

Partyka, Anna, Andrzej Wiśniewski, Irena Porębska, et al.. (2023). The association of BTLA gene polymorphisms with non-small lung cancer risk in smokers and never-smokers. Frontiers in Immunology. 13. 1006639–1006639. 5 indexed citations

Marcinkowska, Monika, Barbara Mordyl, Agata Siwek, et al.. (2022). Hybrid molecules combining GABA-A and serotonin 5-HT6 receptors activity designed to tackle neuroinflammation associated with depression. European Journal of Medicinal Chemistry. 247. 115071–115071. 10 indexed citations

Zagórska, Agnieszka, Adam Bucki, Anna Partyka, et al.. (2022). Design, synthesis, and behavioral evaluation of dual-acting compounds as phosphodiesterase type 10A (PDE10A) inhibitors and serotonin ligands targeting neuropsychiatric symptoms in dementia. European Journal of Medicinal Chemistry. 233. 114218–114218. 5 indexed citations

Śniecikowska, Joanna, Monika Głuch‐Lutwin, Adam Bucki, et al.. (2020). Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT _1A Receptor-Biased Agonists: Diversified Therapeutic-like versus Side Effect Profile. Journal of Medicinal Chemistry. 63(19). 10946–10971. 23 indexed citations

Bucki, Adam, Monika Marcinkowska, Joanna Śniecikowska, et al.. (2020). Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD). European Journal of Medicinal Chemistry. 191. 112149–112149. 9 indexed citations

Latacz, Gniewomir, Annamaria Lubelska, Magdalena Jastrzębska‐Więsek, et al.. (2019). The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment. International Journal of Molecular Sciences. 20(14). 3420–3420. 41 indexed citations

Śniecikowska, Joanna, Monika Głuch‐Lutwin, Adam Bucki, et al.. (2019). Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT_1A Receptor-Biased Agonists with Robust Antidepressant-like Activity. Journal of Medicinal Chemistry. 62(5). 2750–2771. 29 indexed citations

10.

Lubelska, Annamaria, Gniewomir Latacz, Magdalena Jastrzębska‐Więsek, et al.. (2019). Are the Hydantoin-1,3,5-triazine 5-HT6R Ligands a Hope to a Find New Procognitive and Anti-Obesity Drug? Considerations Based on Primary In Vivo Assays and ADME-Tox Profile In Vitro. Molecules. 24(24). 4472–4472. 17 indexed citations

11.

Partyka, Anna, et al.. (2019). 5-HT6 receptor agonist and antagonist improve memory impairments and hippocampal BDNF signaling alterations induced by MK-801. Brain Research. 1722. 146375–146375. 33 indexed citations

12.

Partyka, Anna, Rafał Kurczab, Vittorio Canale, et al.. (2017). The impact of the halogen bonding on D2 and 5-HT1A/5-HT7 receptor activity of azinesulfonamides of 4-[(2-ethyl)piperidinyl-1-yl]phenylpiperazines with antipsychotic and antidepressant properties. Bioorganic & Medicinal Chemistry. 25(14). 3638–3648. 25 indexed citations

13.

Partyka, Anna, Magdalena Jastrzębska‐Więsek, Paweł Mierzejewski, et al.. (2016). ADN-1184, a monoaminergic ligand with 5-HT6/7 receptor antagonist action, exhibits activity in animal models of anxiety. Naunyn-Schmiedeberg s Archives of Pharmacology. 389(6). 593–602. 10 indexed citations

14.

Herold, Franciszek, Anna Wesołowska, Magdalena Jastrzębska‐Więsek, et al.. (2016). Synthesis and biological investigation of new equatorial (β) stereoisomers of 3-aminotropane arylamides with atypical antipsychotic profile. Bioorganic & Medicinal Chemistry. 24(18). 3994–4007. 8 indexed citations

15.

Canale, Vittorio, Rafał Kurczab, Anna Partyka, et al.. (2014). Towards novel 5-HT7 versus 5-HT1A receptor ligands among LCAPs with cyclic amino acid amide fragments: Design, synthesis, and antidepressant properties. Part II. European Journal of Medicinal Chemistry. 92. 202–211. 18 indexed citations

16.

Kołaczkowski, Marcin, Monika Marcinkowska, Adam Bucki, et al.. (2014). Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia. European Journal of Medicinal Chemistry. 92. 221–235. 27 indexed citations

17.

Jastrzębska‐Więsek, Magdalena, Agata Siwek, Grzegorz Kazek, et al.. (2013). Partial agonist efficacy of EMD386088, a 5-HT6 receptor ligand, in functional in vitro assays. Pharmacological Reports. 65(4). 998–1005. 16 indexed citations

18.

Chłoń‐Rzepa, Grażyna, Paweł Żmudzki, Grzegorz Satała, et al.. (2013). New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation. Pharmacological Reports. 65(1). 15–29. 16 indexed citations

19.

Zajdel, Paweł, Krzysztof Marciniec, Andrzej Maślankiewicz, et al.. (2012). Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor—5-HT1A/5-HT2A/5-HT7 and D2/D3/D4—agents: The synthesis and pharmacological evaluation. Bioorganic & Medicinal Chemistry. 20(4). 1545–1556. 58 indexed citations

20.

Partyka, Anna, et al.. (2007). Evaluation of diagnostic value of FDG-PET/CT study in detection of metastases in malignant melanoma patients. Współczesna Onkologia. 11(4). 200–203. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact